Search results
Critics Say FDA's Use of Surrogate Markers Falling Short
Medscape· 10 hours agoAs the FDA's use of surrogate endpoints in the drug approval process is increasing, researchers are...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 1 day agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 3 days agoSanofi plans to invest €1bn in Vitry-sur-Seine to construct a new unit in a bid to double the ...
Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Prurigo Nodularis -...
Benzinga· 2 days agoCelldex Therapeutics, Inc. CLDX today announced that the first patient has been dosed in the Company's Phase 2 subcutaneous study of barzolvolimab in prurigo nodularis (PN). Barzolvolimab is ...
Intel upgraded, Texas Instruments initiated: Wall Street's top analyst calls
The Fly via Yahoo Finance· 1 day agoH.C. Wainwright initiated coverage of Dianthus Therapeutics (DNTH) with a Buy rating and $40 price...
Sanofi boosts French biomanufacturing with €1 billion investment By Investing.com
Investing.com· 4 days agoSanofi (EPA:SASY) (NASDAQ:SNY), a global biopharmaceutical company, announced today a significant...
There's a new highly transmissible COVID-19 variant. Could FLiRT lead to a summer uptick?
Los Angeles Times· 7 days agoTwo new COVID-19 subvariants, collectively nicknamed FLiRT, are increasingly edging out the winter’s...
BioMarin sheds 170 jobs in wake of narrowed R&D refocus
FierceBiotech· 2 days agoBioMarin had already announced plans to cut its pipeline in half, but now the company has confirmed...
Blackstone-backed biotech launches with up to $300M for immune drug
BioPharma Dive via Yahoo Finance· 2 days agoThe drug, solrikitug, originally came from Merck and has the potential to treat a variety of immune...
Eisai projects Leqembi® revenue to total JPY 56.5 billion for fiscal year 2024 (April 2024 - March...
FOX 59 Indianapolis· 2 days agoBioArctic AB's (publ) (NASDAQ STOCKHOLM: BIOA B) partner Eisai today said that they expect Leqembi...